106 related articles for article (PubMed ID: 11605060)
1. Absence of Bcl10 gene mutations in Ewing's sarcomas.
Park YK; Chi SG; Unni KK
Oncol Rep; 2001; 8(6):1333-5. PubMed ID: 11605060
[TBL] [Abstract][Full Text] [Related]
2. Infrequent BCL10 mutations in B-cell non-Hodgkin's lymphomas.
Takahashi H; Hosokawa Y; Suzuki R; Morishima Y; Nakamura S; Seto M
Jpn J Cancer Res; 1999 Dec; 90(12):1316-20. PubMed ID: 10665648
[TBL] [Abstract][Full Text] [Related]
3. Lack of Bcl10 mutations in malignant cartilaginous tumors.
Park YK; Park HR; Kim YW; Chi SG; Unni KK
Int J Mol Med; 2002 Mar; 9(3):217-9. PubMed ID: 11836626
[TBL] [Abstract][Full Text] [Related]
4. BCL10 in malignant lymphomas--an evaluation using fluorescence in situ hybridization.
Achuthan R; Bell SM; Carr IM; Leek JP; Roberts P; Horgan K; Markham AF; Selby PJ; MacLennan KA
J Pathol; 2002 Jan; 196(1):59-66. PubMed ID: 11748643
[TBL] [Abstract][Full Text] [Related]
5. BCL10 gene mutation in lymphoma.
Du MQ; Peng H; Liu H; Hamoudi RA; Diss TC; Willis TG; Ye H; Dogan A; Wotherspoon AC; Dyer MJ; Isaacson PG
Blood; 2000 Jun; 95(12):3885-90. PubMed ID: 10845924
[TBL] [Abstract][Full Text] [Related]
6. Bcl10 expression, rearrangement and mutation in MALT lymphoma: correlation with expression of nuclear factor-kappaB.
Ohshima K; Muta H; Kawasaki C; Muta K; Deyev V; Kanda M; Kumano Y; Podack ER; Kikuchi M
Int J Oncol; 2001 Aug; 19(2):283-9. PubMed ID: 11445840
[TBL] [Abstract][Full Text] [Related]
7. BCL10 gene mutations rarely occur in lymphoid malignancies.
Luminari S; Intini D; Baldini L; Berti E; Bertoni F; Zucca E; Cro L; Maiolo AT; Cavalli F; Neri A
Leukemia; 2000 May; 14(5):905-8. PubMed ID: 10803524
[TBL] [Abstract][Full Text] [Related]
8. BCL10 somatic mutations rarely occur in gastric lymphoma: detection of high frequency of polymorphisms in BCL10 coding region.
Chen YW; Wong KY; Au WY; Liang RH; Srivastava G
Cancer Genet Cytogenet; 2001 Jun; 127(2):184-7. PubMed ID: 11425462
[TBL] [Abstract][Full Text] [Related]
9. Lack of BCL10 mRNA mutation in lymphold malignancies.
Kawano T; Iwase S; Nakayama R; Horiguchi-Yamada J; Kobayashi M; Yamada H
Anticancer Res; 2002; 22(1A):305-9. PubMed ID: 12017308
[TBL] [Abstract][Full Text] [Related]
10. Screening for mutations of Bcl10 in leukaemia.
Grimwade D; Du MQ; Langabeer S; Rogers J; Solomon E
Br J Haematol; 2000 Jun; 109(3):611-5. PubMed ID: 10886211
[TBL] [Abstract][Full Text] [Related]
11. BCL10 is not the gene inactivated by mutation in the 1p22 deletion region in mantle cell lymphoma.
Bullinger L; Leupolt E; Schaffner C; Mertens D; Bentz M; Lichter P; Döhner H; Stilgenbauer S
Leukemia; 2000 Aug; 14(8):1490-2. PubMed ID: 10942247
[TBL] [Abstract][Full Text] [Related]
12. Detection of point mutations of BCL10 gene in hepatocellular carcinoma tissues: report of 46 cases.
Jihua C; Xisheng L; Shengli C; Zongxian C; Guang C; Ruyu D
Hum Mutat; 2000 May; 15(5):482-3. PubMed ID: 10790217
[TBL] [Abstract][Full Text] [Related]
13. Low frequency of BCL10 gene mutations in B-cell non-Hodgkin's lymphoma.
Tadokoro J; Nakamura Y; Furusawa S; Mitani K
Int J Hematol; 2001 Feb; 73(2):222-5. PubMed ID: 11372735
[TBL] [Abstract][Full Text] [Related]
14. MALT lymphoma with t(14;18)(q32;q21)/IGH-MALT1 is characterized by strong cytoplasmic MALT1 and BCL10 expression.
Ye H; Gong L; Liu H; Hamoudi RA; Shirali S; Ho L; Chott A; Streubel B; Siebert R; Gesk S; Martin-Subero JI; Radford JA; Banerjee S; Nicholson AG; Ranaldi R; Remstein ED; Gao Z; Zheng J; Isaacson PG; Dogan A; Du MQ
J Pathol; 2005 Feb; 205(3):293-301. PubMed ID: 15682443
[TBL] [Abstract][Full Text] [Related]
15. Lack of mutations of BCL6 and BCL10 genes in mucosa-associated lymphoid tissue lymphomas of the orbital adnexa.
Chen PM; Liu JH; Yu IT; Kao SC; Lin YC; Chiang H; Fan FS; Chiou TJ; Wang WS; Yen CC
Cancer Genet Cytogenet; 2000 Nov; 123(1):44-8. PubMed ID: 11120333
[TBL] [Abstract][Full Text] [Related]
16. Bcl10 is involved in t(1;14)(p22;q32) of MALT B cell lymphoma and mutated in multiple tumor types.
Willis TG; Jadayel DM; Du MQ; Peng H; Perry AR; Abdul-Rauf M; Price H; Karran L; Majekodunmi O; Wlodarska I; Pan L; Crook T; Hamoudi R; Isaacson PG; Dyer MJ
Cell; 1999 Jan; 96(1):35-45. PubMed ID: 9989495
[TBL] [Abstract][Full Text] [Related]
17. p53 and ras mutations in Ewing's sarcoma.
Radig K; Schneider-Stock R; Röse I; Mittler U; Oda Y; Roessner A
Pathol Res Pract; 1998; 194(3):157-62. PubMed ID: 9587933
[TBL] [Abstract][Full Text] [Related]
18. Absence of post-transcriptional RNA modifications of BCL10 in human malignant mesothelioma and colorectal cancer.
Apostolou S; Murthy SS; Kolachana P; Jhanwar SC; Testa JR
Genes Chromosomes Cancer; 2001 Jan; 30(1):96-8. PubMed ID: 11107182
[TBL] [Abstract][Full Text] [Related]
19. BCL10 is not a major target for frequent loss of 1p in testicular germ cell tumors.
Kakinuma H; Habuchi T; Ito T; Mishina M; Sato K; Satoh S; Akao T; Ogawa O; Kato T
Cancer Genet Cytogenet; 2001 Apr; 126(2):134-8. PubMed ID: 11376806
[TBL] [Abstract][Full Text] [Related]
20. Lack of Bcl10 gene mutations in laryngeal squamous cell carcinoma.
Ronchetti D; Intini D; Pruneri G; Neri A; Pignataro L
J Laryngol Otol; 2002 Aug; 116(8):610-2. PubMed ID: 12389689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
